Glycosmedia - an international diabetes news service from the UK
  
 
Archived News
August 1st 2008
 
 
  NHS spends £750m on drugs to treat lifestyle diseases
  For the first time ever, more money is being spent on treating diabetes than any other single disease (Telegraph, UK)
   
  Diabetes in America
  Public Knowledge, Perceptions and Behaviors (By Gallup for Novo Nordisk National Changing Diabetes® Program. 131-page PDF (NCDP)
   
  USF receives $128 million award for diabetes research
  The National Institutes of Health awarded $128 million to a University of South Florida research team conducting worldwide studies on the prevention and treatment of juvenile diabetes (Business Journal, USA)
   
  Designed for Disease
  The Link Between Local Food Environments and Obesity and Diabetes. 10-page PDF (California Center for Public Health Advocacy, PolicyLink, and the UCLA Center for Health Policy Research)
   
  Joslin Study Finds Insulin Resistance Causes Gallstones
  It has been known for more than 100 years that gallstones are more common in obese individuals. Now, researchers at the Joslin Diabetes Center have determined that insulin resistance is likely the reason why (Joslin Diabetes Center, USA)
   
  AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
  Based on the results of this successful trial, AtheroGenics intends to rapidly move forward with development of AGI-1067 (AtheroGenics, USA)
   
  Oral benfotiamine plus a-lipoic acid normalises complication-causing pathways in type 1 diabetes
  These results show that the previously demonstrated beneficial effects of these agents on complication-causing pathways in rodent models of diabetic complications also occur in humans with type 1 diabetes (Diabetologia)
   
  The Rising Incidence of Type 1 Diabetes Is Accounted for by Cases With Lower-Risk Human Leukocyte Antigen Genotypes
  The rising incidence and decreasing age at diagnosis of type 1 diabetes is accounted for by the impact of environment on children with lower-risk HLA class II genes, who previously would not have developed type 1 diabetes in childhood (Diabetes Care, USA)
   
 
  
© Copyright 2008 Glycosmedia Partnership